Chemoinformaics analysis of 1h-indene, 1-ethylidene-
| Molecular Weight | 164.292 | nRot | 0 |
| Heavy Atom Molecular Weight | 144.132 | nRig | 11 |
| Exact Molecular Weight | 164.156 | nRing | 2 |
| Solubility: LogS | -4.855 | nHRing | 0 |
| Solubility: LogP | 4.259 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 33.3759 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.476 |
| Synth | 3.658 |
| Natural Product Likeliness | 2.248 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.469 |
| MDCK | 0.0000147 |
| BBB | 0.412 |
| PPB | 0.941624 |
| VDSS | 2.709 |
| FU | 0.0277294 |
| CYP1A2-inh | 0.739 |
| CYP1A2-sub | 0.846 |
| CYP2c19-inh | 0.465 |
| CYP2c19-sub | 0.916 |
| CYP2c9-inh | 0.245 |
| CYP2c9-sub | 0.759 |
| CYP2d6-inh | 0.191 |
| CYP2d6-sub | 0.835 |
| CYP3a4-inh | 0.167 |
| CYP3a4-sub | 0.255 |
| CL | 10.022 |
| T12 | 0.158 |
| hERG | 0.009 |
| Ames | 0.022 |
| ROA | 0.033 |
| SkinSen | 0.518 |
| Carcinogencity | 0.167 |
| EI | 0.978 |
| Respiratory | 0.814 |
| NR-Aromatase | 0.102 |
| Antiviral | No |
| Prediction | 0.765833 |